[New molecular mechanisms of nephrotoxicity].
Ortiz
A
A
Nefrología, Fundación Jiménez Díaz, Universidad Autónoma de Madrid, Instituto Reina Sofía de Investigación Nefrológica, Madrid. aortiz@fjd.es
Justo
P
P
Sanz
A
A
Marrón
B
B
Lorz
C
C
D000082:Acetaminophen / Q000009:adverse effects; D017209:Apoptosis / Q000187:drug effects; D053181:Caspase 8; D020169:Caspases / Q000502:physiology; D016572:Cyclosporine / Q000009:adverse effects; D015853:Cysteine Proteinase Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D016207:Cytokines / Q000009:adverse effects; D004721:Endoplasmic Reticulum / Q000187:drug effects; D004848:Epithelium / Q000187:drug effects; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced / Q000378:metabolism; D007684:Kidney Tubules / Q000187:drug effects*; D008928:Mitochondria / Q000187:drug effects; D008954:Models, Biological; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000502:physiology; D051020:bcl-X Protein; D019014:fas Receptor / Q000502:physiology
C494811:BCL2L1 protein, human; D015853:Cysteine Proteinase Inhibitors; D016207:Cytokines; D019253:Proto-Oncogene Proteins c-bcl-2; D051020:bcl-X Protein; D019014:fas Receptor; D000082:Acetaminophen; D016572:Cyclosporine; C505530:CASP8 protein, human; D053181:Caspase 8; D020169:Caspases